# EDGAR Filing Document

**Accession Number:** 0001824884
**File Stem:** 0001213900-23-002032
**Filing Date:** 2023-1
**Character Count:** 5747
**Document Hash:** 06cc5277ddaa40b4c3a8a53a99b41974
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-002032.hdr.sgml**: 20230110

**ACCESSION NUMBER**: 0001213900-23-002032

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230105

**ITEM INFORMATION**: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230110

**DATE AS OF CHANGE**: 20230110

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Edoc Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001824884
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39689
- **FILM NUMBER:** 23521338

**BUSINESS ADDRESS:**
- **STREET 1:** 7612 MAIN STREET FISHERS
- **STREET 2:** SUITE 200
- **CITY:** VICTOR
- **STATE:** NY
- **ZIP:** 14564
- **BUSINESS PHONE:** 5856781198

**MAIL ADDRESS:**
- **STREET 1:** 7612 MAIN STREET FISHERS
- **STREET 2:** SUITE 200
- **CITY:** VICTOR
- **STATE:** NY
- **ZIP:** 14564

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): **January 5, 2023**

**EDOC Acquisition Corp.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-39689** | **N/A** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**7612 Main Street Fishers**

**Suite 200**

**Victor, NY 14564**

(Address of principal executive offices, including zip code)

Registrant's telephone number, including area code: **(585) 678-1198**

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Ordinary Shares, $.0001 par value per share | ADOC | The Nasdaq Stock Market LLC |
| Rights, exchangeable into one-tenth of one Class A Ordinary Share | ADOCR | The Nasdaq Stock Market LLC |
| Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share | ADOCW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.** 

On January 5, 2023, Edoc Acquisition Corp. (the "Company") received written notice from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating the Company's inability to hold its annual meeting of shareholders for the fiscal year ended December 31, 2021 (the "Annual Meeting") pursuant to Nasdaq Listing Rule 5620(a) serves as an additional basis for delisting the Company's securities from Nasdaq.

The Company originally received a determination from the Staff on October 13, 2022 to delist the Company's securities on grounds that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2) because of its failure to meet the minimum Market Value of Listed Securities ("MVLS") requirement for continued listing, since the Company's Class A ordinary shares, par value $0.0001 per share, was below the $35 million minimum MVLS requirement. As reported on the Company's Report on Form 8-K dated December 27, 2022, the Company appealed the Staff's determination and on December 20, 2022, the Nasdaq Hearing's Panel (the "Panel") granted the Company conditional approval to remain listed on Nasdaq until April 11, 2023.

As of January 10, 2023, the Company has submitted a plan of compliance to the Panel with respect to the Annual Meeting deficiency.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 104 | Cover Page Interactive Data File |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 10, 2023

---

| | |
|:---|:---|
| **EDOC ACQUISITION CORP.** | **EDOC ACQUISITION CORP.** |
| By: | */s/ Kevin Chen* |
|  | Name: Kevin Chen |
|  | Title: Chief Executive Officer |

---